PAR 1.82% 28.0¢ paradigm biopharmaceuticals limited..

PAR Investor Meeting - Questions from HC, page-54

  1. 1,576 Posts.
    lightbulb Created with Sketch. 165
    Anyway you can’t use that old “not enough time”
    excuse. Plan so there is enough time.

    Keeping retail shareholders informed is so low
    priority. They try to stifle any information which
    leads to the tiniest hint of negative sentiment.

    Haven’t we the right to know what the hell is
    going on with 008 for example?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.